Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the gut-lung axis by synbiotic feeding to infants in a randomized controlled trial. | BMC Biol | 2023 | 36803508 | PubTator, text mining | PubMed |
| Maltol inhibits oxygen glucose deprivation‑induced chromatinolysis in SH‑SY5Y cells by maintaining pyruvate level. | Mol Med Rep | 2023 | 36799163 | PubTator, text mining | PubMed |
| Kidney Drug Transporters in Pharmacotherapy. | Int J Mol Sci | 2023 | 36769175 | PubTator, text mining | PubMed |
| The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36769116 | PubTator, text mining | PubMed |
| Assessment of the Permeability of 3,4-Methylenedioxypyrovalerone (MDPV) across the Caco-2 Monolayer for Estimation of Intestinal Absorption and Enantioselectivity. | Int J Mol Sci | 2023 | 36768999 | PubTator, text mining | PubMed |
| Polymorphisms Affecting the Response to Novel Antiepileptic Drugs. | Int J Mol Sci | 2023 | 36768858 | PubTator, text mining | PubMed |
| The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of Tyrosine Kinase Inhibitors. | Int J Mol Sci | 2023 | 36768423 | PubTator, text mining | PubMed |
| Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? | Int J Mol Sci | 2023 | 36768264 | PubTator, text mining | PubMed |
| Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial. | Diabetes Metab J | 2023 | 36756676 | PubTator, text mining | PubMed |
| Novel TCF7L2 familial linkage and association with Type 2 diabetes, depression, and their comorbidity. | Eur Rev Med Pharmacol Sci | 2023 | 36734726 | PubTator, text mining | PubMed |
| LMP1 mediates tumorigenesis through persistent epigenetic modifications and PGC1β upregulation. | Oncol Rep | 2023 | 36734290 | PubTator, text mining | PubMed |
| A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer. | Comput Struct Biotechnol J | 2023 | 36733702 | PubTator, text mining | PubMed |
| Prediction model for milk transfer of drugs by primarily evaluating the area under the curve using QSAR/QSPR. | Pharm Res | 2023 | 36720832 | PubTator, text mining | PubMed |
| Identification of hub genes involved in cisplatin resistance in head and neck cancer. | J Genet Eng Biotechnol | 2023 | 36715825 | PubTator, text mining | PubMed |
| Choroidal Vascular Density Quantification in High Myopia with or without Choroidal Neovascularization Using Optical Coherence Tomography Angiography. | J Ophthalmol | 2023 | 36713357 | PubTator, text mining | PubMed |
| Interaction between SIDT2 and ABCA1 Variants with Nutrients on HDL-c Levels in Mexican Adults. | Nutrients | 2023 | 36678241 | PubTator, text mining | PubMed |
| Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions. | Med Oncol | 2023 | 36650399 | PubTator, text mining | PubMed |
| Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study. | Toxicol Sci | 2023 | 36637193 | PubTator, text mining | PubMed |
| A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients. | Drug Res (Stuttg) | 2023 | 36630991 | PubTator, text mining | PubMed |
| A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes. | Int J Med Sci | 2023 | 36619226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=20